Skip to main content
  • mRNA Covid-19 Vaccines and RVO Risk

    By Lynda Seminara
    Selected and reviewed by Neil M. Bressler, MD, and Deputy Editors

    Dorney et al. reviewed health records for several million people who received an mRNA Covid-19 vaccine. They compared retinal vascular occlusion (RVO) incidence among the three types of vaccines and found that the relative risk of new-onset RVO was not more common with the mRNA vaccine.